candidates – Post Vietnam

Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

14/12/2022 acn

FREMONT, CA, Dec 14, 2022 – (ACN Newswire via SEAPRWire.com) – Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company’s groundbreaking research that led to promising novel drug candidates for cardiovascular disease. Cardiovascular disease is the leading cause of death and disability in the […]

AIM Vaccine Announces Global Offering Results, Offer Price of HK$16.16 per H Share

05/10/2022 acn

HONG KONG, Oct 5, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), today announced the allotment results of its Global […]

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

23/09/2022 acn

HONG KONG, Sep 23, 2022 – (ACN Newswire via SEAPRWire.com) – AIM Vaccine Co., Ltd. (“AIM Vaccine” or the “Company”, together with its subsidiaries, the “Group”, stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed listing of its H shares […]